Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation
Sk. Manna et al., Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation, J IMMUNOL, 164(12), 2000, pp. 6509-6519
Resveratrol (trans-3,4',5-trihydroxystilbene), a polyphenolic phytoalexin f
ound in grapes, fruits, and root extracts of the weed Polygonum cuspidatum,
exhibits anti-inflammatory, cell growth-modulatory, and anticarcinogenic e
ffects. How this chemical produces these effects is not known, but it may w
ork by suppressing NP-kappa B, a nuclear transcription factor that regulate
s the expression of various genes involved in inflammation, cytoprotection,
and carcinogenesis. In this study, we investigated the effect of resveratr
ol on NF-kappa B activation induced by various inflammatory agents, Resvera
trol blocked TNF-induced activation of NF-kappa B in a dose- and time-depen
dent manner. Resveratrol also suppressed TNF-induced phosphorylation and nu
clear translocation of the p65 subunit of NF-kappa B, and NF-kappa B-depend
ent reporter gene transcription, Suppression of TNF-induced NF-kappa B acti
vation by resveratrol was not restricted to myeloid cells (U-937); it was a
lso observed in lymphoid (Jurkat) and epithelial (HeLa and H4) cells. Resve
ratrol also blocked NF-kappa B activation induced by PMA, LPS, H2O2, okadai
c acid, and ceramide, The suppression of NF-kappa B coincided with suppress
ion of AP-1, Resveratrol also inhibited the TNF-induced activation of mitog
en-activated protein kinase kinase and c-Jun N-terminal kinase and abrogate
d TNF-induced cytotoxicity and caspase activation. Both reactive oxygen int
ermediate generation and lipid peroxidation induced by TNF were suppressed
by resveratrol. Resveratrol's anticarcinogenic, anti-inflammatory, and grow
th-modulatory effects may thus be partially ascribed to the inhibition of a
ctivation of NF-kappa B and AP-1 and the associated kinases.